| Newland, Jason G |
NCT04180462: Increasing Optimal Use of HPV Vaccination in Primary Care |
|
|
| Completed | N/A | 20 | US | Practice Facilitation, Education, Audit and Feedback, Communication Strategy | Washington University School of Medicine, National Cancer Institute (NCI) | Human Papillomavirus Vaccines | 02/23 | 04/24 | | |
NCT04565509: Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic |
|
|
| Completed | N/A | 3000 | US | General Communication Message, Focused/Targeted Message, Best Message Alone, Best Message + Augmented Message or Implementation Strategy | Washington University School of Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Covid19, Intellectual Disability, Developmental Disability, Child Development Disorder | 03/24 | 03/24 | | |
NCT04875520: Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population |
|
|
| Completed | N/A | 2474 | US | Screening testing strategy, No screening testing strategy | Washington University School of Medicine | Covid19 | 05/23 | 12/23 | | |
| Completed | N/A | 39363 | US | Order set review and modification with facilitation, Order set review and modification | Washington University School of Medicine, Agency for Healthcare Research and Quality (AHRQ) | Surgical Site Infection | 02/24 | 11/24 | | |
| Recruiting | N/A | 52500 | US | Multifaceted de-implementation strategy to reduce vancomycin overuse, Mixed methods intervention | Children's Hospital of Philadelphia, Children's Healthcare of Atlanta, St. Louis Children's Hospital, Johns Hopkins University, University of Pennsylvania, Centers for Disease Control and Prevention | Sepsis, Sepsis Mrsa, Sepsis Bacteremia, Antimicrobial - Induced Nephropathy, Sepsis, Severe, Septic Shock, Septic Syndrome | 08/25 | 01/26 | | |
| Not yet recruiting | N/A | 500 | NA | High Intensity Intervention, Low Intensity Intervention | Denver Health and Hospital Authority, Agency for Healthcare Research and Quality (AHRQ), Vanderbilt University Medical Center, Washington University School of Medicine | Acute Otitis Media, Pediatric Infectious Disease, Ear Infection | 04/27 | 10/27 | | |
| Lu, Esther |
NCT04966481: Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor |
|
|
| Recruiting | 3 | 81 | US | Palbociclib, Ibrance, Cetuximab, Erbitux | Washington University School of Medicine, Pfizer, The Joseph Sanchez Foundation | HPV-unrelated Head and Neck Squamous Cell Carcinoma | 02/27 | 02/27 | | |
NCT04412629: Cabozantinib in High Grade Neuroendocrine Neoplasms |
|
|
| Recruiting | 2 | 32 | US | Cabozantinib, Cabometyx, Blood for plasma biomarkers, Tissue biopsy | Washington University School of Medicine, Exelixis | High Grade Neuroendocrine Neoplasms | 07/25 | 03/26 | | |
NCT04831320: Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor |
|
|
| Active, not recruiting | 2 | 46 | US | nab-paclitaxel, Abraxane, Nivolumab, Opdivo | Washington University School of Medicine, Bristol-Myers Squibb | Metastatic Head-and-neck Squamous-cell Carcinoma | 12/25 | 09/26 | | |
| Not yet recruiting | 2 | 153 | US | Radiation therapy, Cisplatin, Surgery | Washington University School of Medicine, The Joseph Sanchez Foundation | HPV-Related Oropharynx Squamous Cell Carcinoma | 01/30 | 04/33 | | |
NCT05251233: Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy |
|
|
| Terminated | 2 | 56 | US | Placebo, Pantoprazole | Washington University School of Medicine | Pancreatic Cancer, Pancreas Cancer, Ampullary Cancer, Pancreas Neuroendocrine Tumor, Pancreatitis, Distal Extrahepatic Cholangiocarcinoma, Duodenal Cancer | 06/24 | 06/24 | | |
NCT04852328: Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma |
|
|
| Recruiting | 2 | 30 | US | CUE-101 | Washington University School of Medicine, Cue Biopharma | Oropharyngeal Squamous Cell Carcinoma | 10/27 | 10/27 | | |
NCT04643379: Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma |
|
|
| Active, not recruiting | 2 | 30 | US | Olaparib, Lynparza, Pembrolizumab, Keytruda, Carboplatin, Peripheral blood draw | Washington University School of Medicine, Merck Sharp & Dohme LLC, Joseph Sanchez Foundation | Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma | 11/25 | 11/26 | | |
NCT04331041: Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma |
|
|
| Recruiting | 2 | 42 | US | Adaptive stereotactic body radiation therapy, Adaptive SBRT, Defactinib, VS-6063, PF-04554878, Tumor biopsy, Research blood draw | Washington University School of Medicine, National Cancer Institute (NCI), Verastem, Inc. | Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma | 06/27 | 06/28 | | |
Rambro2, NCT05980000: Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma |
|
|
| Recruiting | 2 | 72 | US | Ramucirumab, Cyramza, Pembrolizumab, MK-3475, Keytruda | Washington University School of Medicine, Eli Lilly and Company | Recurrent Head and Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Metastatic Head and Neck Cancer, HNSCC | 04/28 | 04/31 | | |
NCT05903131: A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia |
|
|
| Recruiting | 2 | 96 | US | Telemedicine behavioral weight intervention, Progestin, Enhanced usual care, Levonorgestrel-releasing IUD. | Washington University School of Medicine, National Cancer Institute (NCI) | Endometrial Hyperplasia, Grade 1 Endometrial Cancer | 10/28 | 10/29 | | |
NCT05829460: Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia |
|
|
| Not yet recruiting | 2 | 96 | US | Semaglutide, Placebo, LNG-IUD (Progestin), Telemedicine behavioral weight program | Washington University School of Medicine, Novo Nordisk A/S | Endometrial Hyperplasia | 12/29 | 12/31 | | |
NCT05521997: Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer |
|
|
| Not yet recruiting | 2 | 42 | US | Telaglenastat, CB-893, Radiation treatment, Cisplatin | Washington University School of Medicine, National Cancer Institute (NCI), Calithera Biosciences, Inc | Advanced Cervical Carcinoma, Cervical Cancer, Cervix Cancer, Cancer of the Cervix | 04/31 | 04/31 | | |
NCT06529809: Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer |
|
|
| Recruiting | 1/2 | 50 | US | Hypofractionated external beam radiation, Chemotherapy, Image-guided brachytherapy | Washington University School of Medicine | Locally Advanced Cervical Carcinoma | 12/31 | 12/31 | | |
NCT05616624: ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers |
|
|
| Recruiting | 1/2 | 114 | US | ADI-PEG 20, PEGylated arginine deiminase, Gemcitabine, Gemzar, Docetaxel, Taxotere | Washington University School of Medicine, Polaris Group | Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Small-cell Lung Cancer, Small Cell Lung Carcinoma | 12/27 | 12/32 | | |
NCT03516708: Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer |
|
|
| Recruiting | 1/2 | 49 | US | Epacadostat, INCB024360, Short-course radiation therapy, SCRT, CAPOX chemotherapy, FOLFOX chemotherapy | Washington University School of Medicine, Incyte Corporation, National Cancer Institute (NCI) | Rectal Cancer | 07/27 | 08/30 | | |
|
NCT04624113: Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma |
|
|
| Terminated | 1 | 13 | US | Tazemetostat, Tazverik, Pembrolizumab, Keytruda | Washington University School of Medicine, Epizyme, Inc. | Head and Neck Squamous Cell Carcinoma | 08/22 | 02/24 | | |
NCT06648434: MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma |
|
|
| Not yet recruiting | 1 | 51 | US | Zunsemetinib, ATI-450, mFOLFIRINOX | Washington University School of Medicine, National Cancer Institute (NCI), Aclaris Therapeutics, Inc. | Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Cancer of the Pancreas | 04/27 | 03/30 | | |
NCT06795009: Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer |
|
|
| Not yet recruiting | 1 | 36 | US | Zanzalintinib, XL092, Paclitaxel, Taxol | Washington University School of Medicine, National Cancer Institute (NCI), Exelixis | Uterine Cancer, Endometrial Cancer | 06/29 | 11/34 | | |
NCT05678348: Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma |
|
|
| Recruiting | 1 | 21 | US | Pyrimethamine, Daraprim | Washington University School of Medicine, Tilde Sciences | Head and Neck Cancer, Cancer of the Head and Neck | 04/26 | 04/26 | | |
NCT05826015: AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer |
|
|
| Withdrawn | 1 | 36 | NA | Paclitaxel, Taxol, Batiraxcept, AVB-500 | Washington University School of Medicine, National Cancer Institute (NCI), Aravive, Inc. | Recurrent High Grade Uterine Cancer | 06/29 | 06/34 | | |
NCT04508764: Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome |
|
|
| Terminated | N/A | 96 | US | Families Accelerating Cascade Testing Toolkit, FACTT | Washington University School of Medicine, The Foundation for Barnes-Jewish Hospital | Hereditary Breast and Ovarian Cancer, Lynch Syndrome | 03/24 | 03/24 | | |
NCT05179837: Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps |
|
|
| Active, not recruiting | N/A | 36 | US | Optical coherence tomography probe, OCT probe | Washington University School of Medicine | Colon Cancer, Rectal Cancer, Cancer of the Rectum, Cancer of the Colon, Precancerous Polyp, Malignant Polyp | 04/23 | 12/24 | | |
NCT04651504: Rural Colon Cancer Screening Toolkit Intervention |
|
|
| Recruiting | N/A | 83663 | US | Colorectal Cancer Toolkit | Washington University School of Medicine, National Institutes of Health (NIH), National Cancer Institute (NCI) | Colon Cancer Screening | 07/25 | 07/25 | | |
NCT05762757: Patient-centered Educational Material to Improve Colposcopy Adherence |
|
|
| Completed | N/A | 25 | US | Colposcopy educational material | Washington University School of Medicine, American Association of Obstetricians and Gynecologists | Cervical Cancer Screening | 09/24 | 09/24 | | |
| Active, not recruiting | N/A | 63 | US | Radiation therapy, FOLFOX regimen, Functional Assessment of Cancer Therapy-Colorectal cancer (FACT-C) questionnaire, Rectal biopsy samples, Blood for ctDNA | Washington University School of Medicine | Adenocarcinoma of the Lower Rectum | 08/24 | 04/26 | | |
| Not yet recruiting | N/A | 81 | US | Social needs navigator program, Enhanced usual care | Washington University School of Medicine, National Center for Advancing Translational Sciences (NCATS) | Cervical Cancer | 07/26 | 11/26 | | |
SORT, NCT05183932: Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer |
|
|
| Recruiting | N/A | 440 | Canada, US | | Washington University School of Medicine, National Cancer Institute (NCI) | Non Small Cell Lung Cancer, Non-small Cell Lung Cancer | 01/27 | 01/27 | | |
| Recruiting | N/A | 850 | US | Precision Treatment, Usual Care | Washington University School of Medicine, National Institute on Drug Abuse (NIDA), National Cancer Institute (NCI) | Physician's Role, Smoking Cessation, Smoking | 03/28 | 09/28 | | |
NCT04178018: Transvaginal Ultrasound and Photoacoustic Imaging of Ovary |
|
|
| Recruiting | N/A | 310 | US | Photoacoustic imaging, PAI, Photoacoustic tomography, Ultrasound | Washington University School of Medicine, National Cancer Institute (NCI) | Ovary; Anomaly | 01/27 | 01/27 | | |
| Recruiting | N/A | 60 | US | Tumor collection via biopsy, Blood collection, Diffusion basis spectrum imaging (DBSI) magnetic resonance imaging (MRI), DBSI MRI | Washington University School of Medicine, National Cancer Institute (NCI) | Locally Advanced Cervical Carcinoma, Locally Advanced Cervical Cancer, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Cancer, Cervical Cancer, Pancreas Cancer, Pancreatic Cancer, Cancer of the Cervix, Cancer of the Pancreas | 12/32 | 12/32 | | |
| McKay, Virginia |
| No trials found |
